The Alzheimer's Association is awarding a new series of grants to support research on non-drug therapies for the treatment of Alzheimer's disease as a way of advancing the search for a cure for the condition and meeting the needs of projects that are not funded either by the government or pharmaceutical companies. The Alzheimer's Association International Research Grant Program (IRGP) is supporting 42 projects, including three for non-drug therapies and 15 for fields identified as in critical need of more research.
The new grants awarded three research projects from the University of California in San Diego, the Joslin Diabetes Center in Boston, and the University of Oklahoma Health Sciences, who are working on non-drug therapies, under the conviction that these kinds of treatments currently being researched may offer a new opportunity to improve Alzheimer's patients' quality of life. Moreover, the association is sensitive to the fact that several recent late-stage drug trials were unproductive.
"The Alzheimer's Association International Research Grant Program (IRGP) is at the heart of the association's commitment to advancing Alzheimer's research," said the vice president of Medical and Scientific Rel